| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |